| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |